These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3576002)

  • 1. [Role of ketanserin--a serotonin antagonist--in the treatment of arterial hypertension].
    Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(3):559-60. PubMed ID: 3576002
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
    Kay R; Poon WS; Nicholls MG
    J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
    Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
    Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 7. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
    Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
    Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
    Popova NK; Piianzin AI; Markel' AL
    Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
    Lichtenthal PR; Wade LD; Rossi EC
    Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin].
    Prostran M
    Srp Arh Celok Lek; 1994; 122(3-4):99-102. PubMed ID: 17972821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR; Amstein R
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotonin antagonists for the treatment of hypertension].
    Bühler FR
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1259-60. PubMed ID: 3175572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ketanserin. Lowering blood pressure using serotonin antagonists].
    Uhl D
    Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
    Sechi LA
    Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential arterial hypertension and Leriche-Fontaine stage II obliterating vascular disease of the lower limbs. A new pharmacological approach with ketanserin].
    Mollo P
    Clin Ter; 1991 Apr; 137(2):113-5. PubMed ID: 1828404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symposium. Ketanserin: Serotonin antagonism is a new therapeutic principle in the older hypertensive patient. 24 September 1988, Frankfurt. Abstracts].
    Internist (Berl); 1988 Dec; 29(12 Suppl):1-12. PubMed ID: 3065279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of ketanserin in the treatment of arterial hypertension].
    Cricco L
    Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.